275 related articles for article (PubMed ID: 24865286)
1. Peri-tumoral leakage during intra-tumoral convection-enhanced delivery has implications for efficacy of peri-tumoral infusion before removal of tumor.
Yang X; Saito R; Nakamura T; Zhang R; Sonoda Y; Kumabe T; Forsayeth J; Bankiewicz K; Tominaga T
Drug Deliv; 2016; 23(3):781-6. PubMed ID: 24865286
[TBL] [Abstract][Full Text] [Related]
2. Convection-enhanced delivery of polyethylene glycol-coated liposomal doxorubicin: characterization and efficacy in rat intracranial glioma models.
Kikuchi T; Saito R; Sugiyama S; Yamashita Y; Kumabe T; Krauze M; Bankiewicz K; Tominaga T
J Neurosurg; 2008 Nov; 109(5):867-73. PubMed ID: 18976076
[TBL] [Abstract][Full Text] [Related]
3. Concentration rather than dose defines the local brain toxicity of agents that are effectively distributed by convection-enhanced delivery.
Zhang R; Saito R; Mano Y; Kanamori M; Sonoda Y; Kumabe T; Tominaga T
J Neurosci Methods; 2014 Jan; 222():131-7. PubMed ID: 24269253
[TBL] [Abstract][Full Text] [Related]
4. Local convection-enhanced delivery of chemotherapeutic agent transiently opens blood-brain barrier and improves efficacy of systemic chemotherapy in intracranial xenograft tumor model.
Nakamura T; Saito R; Sugiyama S; Sonoda Y; Kumabe T; Tominaga T
Cancer Lett; 2011 Nov; 310(1):77-83. PubMed ID: 21763069
[TBL] [Abstract][Full Text] [Related]
5. Convection-enhanced delivery of a topoisomerase I inhibitor (nanoliposomal topotecan) and a topoisomerase II inhibitor (pegylated liposomal doxorubicin) in intracranial brain tumor xenografts.
Yamashita Y; Krauze MT; Kawaguchi T; Noble CO; Drummond DC; Park JW; Bankiewicz KS
Neuro Oncol; 2007 Jan; 9(1):20-8. PubMed ID: 17018695
[TBL] [Abstract][Full Text] [Related]
6. Safety and feasibility of convection-enhanced delivery of nimustine hydrochloride co-infused with free gadolinium for real-time monitoring in the primate brain.
Sugiyama S; Saito R; Nakamura T; Yamashita Y; Yokosawa M; Sonoda Y; Kumabe T; Watanabe M; Tominaga T
Neurol Res; 2012 Jul; 34(6):581-7. PubMed ID: 22709625
[TBL] [Abstract][Full Text] [Related]
7. Convection enhanced delivery of liposome encapsulated doxorubicin for brain tumour therapy.
Zhan W; Wang CH
J Control Release; 2018 Sep; 285():212-229. PubMed ID: 30009891
[TBL] [Abstract][Full Text] [Related]
8. Safety and efficacy of convection-enhanced delivery of ACNU, a hydrophilic nitrosourea, in intracranial brain tumor models.
Sugiyama S; Yamashita Y; Kikuchi T; Saito R; Kumabe T; Tominaga T
J Neurooncol; 2007 Mar; 82(1):41-7. PubMed ID: 17031554
[TBL] [Abstract][Full Text] [Related]
9. Tissue affinity of the infusate affects the distribution volume during convection-enhanced delivery into rodent brains: implications for local drug delivery.
Saito R; Krauze MT; Noble CO; Tamas M; Drummond DC; Kirpotin DB; Berger MS; Park JW; Bankiewicz KS
J Neurosci Methods; 2006 Jun; 154(1-2):225-32. PubMed ID: 16472868
[TBL] [Abstract][Full Text] [Related]
10. Distribution of polymer nanoparticles by convection-enhanced delivery to brain tumors.
Saucier-Sawyer JK; Seo YE; Gaudin A; Quijano E; Song E; Sawyer AJ; Deng Y; Huttner A; Saltzman WM
J Control Release; 2016 Jun; 232():103-12. PubMed ID: 27063424
[TBL] [Abstract][Full Text] [Related]
11. Intraparenchymal ultrasound application and improved distribution of infusate with convection-enhanced delivery in rodent and nonhuman primate brain.
Mano Y; Saito R; Haga Y; Matsunaga T; Zhang R; Chonan M; Haryu S; Shoji T; Sato A; Sonoda Y; Tsuruoka N; Nishiyachi K; Sumiyoshi A; Nonaka H; Kawashima R; Tominaga T
J Neurosurg; 2016 May; 124(5):1490-500. PubMed ID: 26495939
[TBL] [Abstract][Full Text] [Related]
12. Convection enhanced delivery of chemotherapeutic drugs into brain tumour.
Zhan W; Wang CH
J Control Release; 2018 Feb; 271():74-87. PubMed ID: 29274437
[TBL] [Abstract][Full Text] [Related]
13. Convection-enhanced Delivery of Therapeutics for Malignant Gliomas.
Saito R; Tominaga T
Neurol Med Chir (Tokyo); 2017 Jan; 57(1):8-16. PubMed ID: 27980285
[TBL] [Abstract][Full Text] [Related]
14. Convection-enhanced delivery in clinical trials.
Hall WA; Rustamzadeh E; Asher AL
Neurosurg Focus; 2003 Feb; 14(2):e2. PubMed ID: 15727423
[TBL] [Abstract][Full Text] [Related]
15. Convection-enhanced delivery of nanoliposomal CPT-11 (irinotecan) and PEGylated liposomal doxorubicin (Doxil) in rodent intracranial brain tumor xenografts.
Krauze MT; Noble CO; Kawaguchi T; Drummond D; Kirpotin DB; Yamashita Y; Kullberg E; Forsayeth J; Park JW; Bankiewicz KS
Neuro Oncol; 2007 Oct; 9(4):393-403. PubMed ID: 17652269
[TBL] [Abstract][Full Text] [Related]
16. Intraparenchymal and intratumoral interstitial infusion of anti-glioma monoclonal antibody 8H9.
Luther N; Cheung NK; Dunkel IJ; Fraser JF; Edgar MA; Gutin PH; Souweidane MM
Neurosurgery; 2008 Dec; 63(6):1166-74; discussion 1174. PubMed ID: 19057330
[TBL] [Abstract][Full Text] [Related]
17. Imaging of convection enhanced delivery of toxins in humans.
Mehta AI; Choi BD; Raghavan R; Brady M; Friedman AH; Bigner DD; Pastan I; Sampson JH
Toxins (Basel); 2011 Mar; 3(3):201-6. PubMed ID: 22069706
[TBL] [Abstract][Full Text] [Related]
18. Convection enhanced drug delivery of novel therapeutic agents to malignant brain tumors.
Ferguson S; Lesniak MS
Curr Drug Deliv; 2007 Apr; 4(2):169-80. PubMed ID: 17456036
[TBL] [Abstract][Full Text] [Related]
19. Induction of hyperintense signal on T2-weighted MR images correlates with infusion distribution from intracerebral convection-enhanced delivery of a tumor-targeted cytotoxin.
Sampson JH; Raghavan R; Provenzale JM; Croteau D; Reardon DA; Coleman RE; Rodríguez Ponce I; Pastan I; Puri RK; Pedain C
AJR Am J Roentgenol; 2007 Mar; 188(3):703-9. PubMed ID: 17312057
[TBL] [Abstract][Full Text] [Related]
20. Drug-carrying microbubbles as a theranostic tool in convection-enhanced delivery for brain tumor therapy.
Chen PY; Yeh CK; Hsu PH; Lin CY; Huang CY; Wei KC; Liu HL
Oncotarget; 2017 Jun; 8(26):42359-42371. PubMed ID: 28418846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
